Search

everythinglearnresearchcommunity

for

Search:↓

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Ginseng was more effective than finasteride in treating enlarged prostate in rats.

The study's methods are flawed, making its conclusions about finasteride and mental health unreliable.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

Finasteride users have a very low risk of mental health issues, but those with hair loss may have slightly higher anxiety and depression.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Men with male pattern baldness are more likely to have benign prostatic hyperplasia.

Urinary PSA could be an early marker for enlarged prostate.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Gene variation affects prostate issues and hair loss.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Finasteride does not prevent bladder cancer.

Hair loss gene linked to prostate issues.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.